Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 33% ± 13% | |
basal cell | 3 studies | 37% ± 24% |
Insufficient scRNA-seq data for expression of CTSV at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 36% | 446.95 | 518 / 1445 | 91% | 28.88 | 166 / 183 |
stomach | 43% | 121.03 | 154 / 359 | 78% | 14.26 | 223 / 286 |
skin | 78% | 2689.19 | 1414 / 1809 | 34% | 3.63 | 161 / 472 |
uterus | 8% | 102.97 | 14 / 170 | 91% | 44.22 | 417 / 459 |
tonsil | 0% | 0 | 0 / 0 | 98% | 46.08 | 44 / 45 |
intestine | 14% | 42.70 | 138 / 966 | 75% | 15.65 | 395 / 527 |
ovary | 4% | 11.55 | 7 / 180 | 76% | 11.17 | 325 / 430 |
kidney | 75% | 486.83 | 67 / 89 | 4% | 0.43 | 36 / 901 |
lung | 11% | 31.78 | 65 / 578 | 66% | 16.92 | 761 / 1155 |
pancreas | 22% | 52.78 | 72 / 328 | 47% | 5.61 | 83 / 178 |
breast | 26% | 90.02 | 121 / 459 | 42% | 6.07 | 467 / 1118 |
bladder | 0% | 0 | 0 / 21 | 60% | 14.08 | 302 / 504 |
thymus | 9% | 16.90 | 57 / 653 | 17% | 98.95 | 103 / 605 |
eye | 0% | 0 | 0 / 0 | 25% | 1.49 | 20 / 80 |
brain | 13% | 45.42 | 352 / 2642 | 6% | 0.53 | 41 / 705 |
liver | 0% | 0.88 | 1 / 226 | 17% | 3.60 | 70 / 406 |
prostate | 6% | 13.82 | 15 / 245 | 6% | 0.38 | 30 / 502 |
adrenal gland | 0% | 0 | 0 / 258 | 10% | 1.06 | 22 / 230 |
adipose | 1% | 2.99 | 11 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.98 | 4 / 803 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.64 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 2.74 | 1 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 3.04 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019886 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO_0006915 | Biological process | apoptotic process |
GO_0006955 | Biological process | immune response |
GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0010952 | Biological process | positive regulation of peptidase activity |
GO_0005615 | Cellular component | extracellular space |
GO_0005764 | Cellular component | lysosome |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0008234 | Molecular function | cysteine-type peptidase activity |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | CTSV |
Protein name | Cathepsin V Cathepsin L2 (EC 3.4.22.43) (Cathepsin U) (Cathepsin V) |
Synonyms | CTSU CTSL2 UNQ268/PRO305 CATL2 |
Description | FUNCTION: Cysteine protease. May have an important role in corneal physiology. . |
Accessions | A0A7P0Z415 ENST00000538255.6 ENST00000259470.6 A0A7P0T983 O60911 ENST00000680787.1 ENST00000681927.1 ENST00000680385.1 ENST00000680221.1 A0A7P0T891 ENST00000679661.1 ENST00000681737.1 ENST00000680490.1 A0A804EQJ3 ENST00000681330.1 A0A7P0T8X8 |